Smile:
[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)[C@H](N)CC1=CC=CC=C1)[C@@H](C)O
IUPAC:
(4R,7S,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-[(1H-indol-3-yl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
IUPAC Traditional:
(4R,7S,10S,13R,16S,19R)-19-[(2R)-2-amino-3-phenylpropanamido]-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
Drug Group:
approved; investigational
Synonyms:
Octreotida; Octreotide; Octreotidum; Octrotide
Product:
Ocphyl; Octreotide; Octreotide Acetate; Octreotide Acetate Injection - 100mcg/ml; Octreotide Acetate Injection - 200mcg/ml; Octreotide Acetate Injection - 500mcg/ml; Octreotide Acetate Injection - 50mcg/ml; Octreotide Acetate Omega; Octreotide Injection; Octreotide acetate; Sandostatin; Sandostatin 100mcg/ml; Sandostatin 200mcg/ml; Sandostatin 500mcg/ml; Sandostatin 50mcg/ml; Sandostatin LAR Depot; Sandostatin LAR Depot Demonstration kit; Sandostatin Lar 10mg; Sandostatin Lar 20mg; Sandostatin Lar 30mg